Marketplace Morning Report for Tuesday, July 3, 2012
The London-based financial services giant Barclays is accused of rigging the level of a key interest rate; now both is chairman of the board and CEO Bob Diamond are stepping down. A group of former bank regulators, company CEOs and U.S. senators is trying to make some waves in Washington this election year. GlaxoSmithKline, the huge British drug-maker, will pay $3 billion in fines and compensation to the U.S. government and the states for pushing doctors to prescribe drugs for uses that weren't approved by the FDA. And in many towns in America this Fourth of July, fear of forest fires is leading to cancelled fireworks displays.
The London-based financial services giant Barclays is accused of rigging the level of a key interest rate; now both is chairman of the board and CEO Bob Diamond are stepping down. A group of former bank regulators, company CEOs and U.S. senators is trying to make some waves in Washington this election year. GlaxoSmithKline, the huge British drug-maker, will pay $3 billion in fines and compensation to the U.S. government and the states for pushing doctors to prescribe drugs for uses that weren’t approved by the FDA. And in many towns in America this Fourth of July, fear of forest fires is leading to cancelled fireworks displays.
